India may tweak pricing policy amid finance ministry opposition
This article was originally published in Scrip
Executive Summary
India's new drug pricing policy may be subject to some fine-tuning following objections raised by the finance ministry which is said to be backing the existing cost-plus mechanism over the proposed market-based one.